The Polycomb BMI1 Protein Is Co-expressed With CD26+ in Leukemic Stem Cells of Chronic Myeloid Leukemia

The Polycomb gene BMI1 expression exerts a negative predictive impact on several hematological malignancies, such as acute and chronic myeloid leukemia (CML), myelofibrosis, and follicular lymphoma. As already demonstrated in CML, BMI1 is responsible for the resistance to the tyrosine kinase inhibit...

Descripción completa

Detalles Bibliográficos

Autores principales:	Sara Galimberti, Susanna Grassi, Claudia Baratè, Francesca Guerrini, Elena Ciabatti, Francesca Perutelli, Federica Ricci, Giada Del Genio, Marina Montali, Serena Barachini, Cecilia Giuliani, Maria Immacolata Ferreri, Angelo Valetto, Elisabetta Abruzzese, Chiara Ippolito, Alessandra Iurlo, Monica Bocchia, Anna Sicuranza, Bruno Martino, Lorenzo Iovino, Gabriele Buda, Serena Salehzadeh, Mario Petrini, Antonello Di Paolo, Letizia Mattii
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Frontiers Media S.A. 2018-12-01
Colección:	Frontiers in Oncology
Materias:	BMI1 polycomb BCR-ABL1 CML CD26 leukemic stem cell
Acceso en línea:	https://www.frontiersin.org/article/10.3389/fonc.2018.00555/full
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!